Teleflex (NYSE:TFX) Announces Quarterly Earnings Results

Teleflex (NYSE:TFX) released its earnings results on Thursday. The medical technology company reported $3.42 EPS for the quarter, topping analysts’ consensus estimates of $3.33 by $0.09, Briefing.com reports. Teleflex had a return on equity of 14.51% and a net margin of 8.76%. The company had revenue of $749.70 million for the quarter, compared to the consensus estimate of $762.98 million. During the same quarter last year, the business posted $3.41 EPS. Teleflex’s quarterly revenue was up .9% compared to the same quarter last year. Teleflex updated its FY24 guidance to $13.80-14.20 EPS and its FY 2024 guidance to 13.800-14.200 EPS.

Teleflex Price Performance

Teleflex stock traded up $1.18 during trading hours on Friday, hitting $237.13. 745,171 shares of the company traded hands, compared to its average volume of 392,632. Teleflex has a 1-year low of $177.63 and a 1-year high of $257.85. The firm has a market cap of $11.17 billion, a P/E ratio of 38.06, a P/E/G ratio of 2.26 and a beta of 1.13. The firm’s 50-day simple moving average is $214.14 and its two-hundred day simple moving average is $221.29. The company has a quick ratio of 1.41, a current ratio of 2.58 and a debt-to-equity ratio of 0.36.

Teleflex Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, September 16th. Investors of record on Thursday, August 15th will be paid a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.57%. The ex-dividend date of this dividend is Thursday, August 15th. Teleflex’s dividend payout ratio is currently 21.83%.

Wall Street Analysts Forecast Growth

TFX has been the topic of several research analyst reports. Royal Bank of Canada raised their price objective on Teleflex from $235.00 to $260.00 and gave the stock an “outperform” rating in a research note on Friday. Piper Sandler raised shares of Teleflex from a “neutral” rating to an “overweight” rating and lifted their price target for the company from $205.00 to $245.00 in a report on Monday, July 1st. Stephens increased their price objective on shares of Teleflex from $275.00 to $290.00 and gave the stock an “overweight” rating in a research note on Friday. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a research note on Friday, May 3rd. Finally, Truist Financial raised their price target on Teleflex from $235.00 to $240.00 and gave the stock a “hold” rating in a report on Tuesday, July 16th. Three investment analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $264.57.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.